Dr.Ramayya's: Prostate biopsy

Links shared publicly online about this topic.

  • 1,306
    total visits

Dr.Ramayya's: Prostate biopsy

drramayyas.blogspot.com

Dr.Ramayya's: Prostate biopsy

View full resource at drramayyas.blogspot.com

Tags: Prostate, Men's Health

  • Share

Most Recently Shared on March 18, 2010 at 9:19 am By:

using fusion to create a smarter prostate biopsy | Dr. Scionti

drscionti.com — “Fusion is powerful because it combines real-time high resolution 3D ultrasound with structural 3D MRI prostate images. This result significantly enhances prostate examination and biopsy sampling.View full resource at drscionti.com

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 7:26 pm By:

drscionti Stephen Scionti, MD Doctor, Surgeon, Urologist, and Physician

Read my latest article on Using Fusion To Create A Smarter Prostate Biopsy http://t.co/SG309k2u

3 weeks ago...

Urologist’s Stake in Laboratory Affects Number of Prostate Biopsies - NYTimes.com

nytimes.com — “Doctors with a financial interest in a laboratory are more likely to send prostate samples, according to a new study, but the rate of cancer detection is no higher.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 1:06 am By:

nytimesscience NYTimes Science Science Enthusiast

Vital Signs: Urologist’s Stake in Laboratory Affects Number of Prostate Biopsies http://t.co/XZb3Ohki

3 weeks ago...

Urology News - Is sampling transitional zone in patients who had prior negative prostate biopsy necessary |3985683

mdlinx.com — “Urology Medical Article: Is sampling transitional zone in patients who had prior negative prostate biopsy necessaryView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 7:37 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Is sampling transitional zone in patients who had prior negative prostate biopsy necessary: Internation... http://t.co/Iuw9Nbk2 #urology

1 month ago...

Lowering risk of infections associated with TRUS-guided prostate biopsy: a new standard of care? « THE "NEW" PROSTATE CANCER INFOLINK

prostatecancerinfolink.net — “Lowering risk of infections associated with TRUS-guided prostate biopsy: a new standard of care? « THE "NEW" PROSTATE CANCER INFOLINKView full resource at prostatecancerinfolink.net

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 7:35 pm By:

prostatediaries john clay mchugh Doctor, Surgeon, Urologist, and Physician

Lowering risk of infections associated with TRUS-guided prostate biopsy: a new standard of care?: A study just p... http://t.co/SkNLOL9N

1 month ago...

Can PCA3 Prevent Unnecessary Prostate Biopsies? - Topix

topix.com — “Can PCA3 Prevent Unnecessary Prostate Biopsies? - TopixView full resource at topix.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 5:19 am By:

prostatediaries john clay mchugh Doctor, Surgeon, Urologist, and Physician

Can PCA3 Prevent Unnecessary Prostate Biopsies?: 1 Comment, last updated on Thursday Mar 22 by prostate doc http://t.co/JdvF2Txc

1 month ago...

Opko Health Expands Collaboration with Arctic Partners | IVD Technology

ivdtechnology.com — “Opko Health Inc. announced an expansion of the previously announced exclusive licensing deal with Arctic Partners Ab Oy (Turku, Finland) for two biomarkers in the kallikrein family which used together with prostate specific antigen (PSA)can reduce the need for prostate biopsies by over 50%.View full resource at ivdtechnology.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 5:33 pm By:

ivdtechnology IVD Technology Health Magazine

Opko Health Expands Collaboration with Arctic Partners http://t.co/KNFiy4aC

2 months ago...

Urology News - Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort |3975740

mdlinx.com — “Urology Medical Article: Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohortView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 3:13 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Prospective validation of a risk calculator which calculates the probability of a positive prostate bio... http://t.co/u383SX2k #urology

2 months ago...

Oncology News - Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort |3975740

mdlinx.com — “Oncology Medical Article: Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohortView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 1:36 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Prospective validation of a risk calculator which calculates the probability of a positive prostate bi... http://t.co/4xgp3mFH #oncology

2 months ago...

Oncology News - Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy |3980905

mdlinx.com — “Oncology Medical Article: Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 8:24 am By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer ... http://t.co/NlNWZELq #oncology

2 months ago...

AUA revises statement on antibiotic prophylaxis for prostate Bx - - ModernMedicine

modernmedicine.com — “The AUA has revised its best practice statement on antibiotic prophylaxis for transrectal prostate biopsy to incorporate recent Centers for Medicare & Medicaid Services approval of intramuscular administration of antimicrobials.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 9:29 pm By:

HealthInsure_OW Health Insurance OW OW Health

AUA revises statement on antibiotic prophylaxis for prostate Bx: The AUA has revised its best practice statement... http://t.co/itnSpEdb

2 months ago...

AUA revises statement on antibiotic prophylaxis for prostate Bx - - UrologyTimes

urologytimes.modernmedicine.com — “The AUA has revised its best practice statement on antibiotic prophylaxis for transrectal prostate biopsy to incorporate recent Centers for Medicare & Medicaid Services approval of intramuscular administration of antimicrobials.View full resource at urologytimes.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 9:48 pm By:

HealthInsure_OW Health Insurance OW OW Health

AUA revises statement on antibiotic prophylaxis for prostate Bx: The AUA has revised its best practice statement... http://t.co/YxU7hTlf

2 months ago...

Overdiagnosis as a Flaw in Health Care - NYTimes.com

nytimes.com — “Is looking hard for things to be wrong a good way to promote health?View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on February 28, 2012 at 1:23 pm By:

kidney_boy Dr Joel Topf Internist, Nephrologist, Physician, and Doctor

Hospitals could make $5,000 from free prostate cancer screening, thanks to the follow-up biopsies and treatments. http://t.co/OzOrfG6e

2 months ago...

Gen-Probe receives FDA approval for PROGENSA PCA3 assay

news-medical.net — “DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high?value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 16, 2012 at 9:05 am By:

Genetics_News News-Medical.Net Health News

Genetics News: Gen-Probe receives FDA approval for PROGENSA PCA3 assay: DiagnoCure, Inc., a Quebec life sciences... http://t.co/odTzFYgG

3 months ago...

International Scientific Cooperation to Advance Image-Guided Prostate Cancer Care

acr.org — “To improve early diagnosis and treatment of prostate cancer, ACR, AdMeTech Foundation and ESUR have formed a joint effort to expedite development of standards for the Magnetic Resonance Prostate Imaging Reporting and Data System (MR PI-RADS) modeled after a successful effort in breast cancer care. The goal is to expedite the transfer of high-quality MRI from laboratories to patients to address the major need in prostate cancer care — reducing unnecessary biopsies and treatment.View full resource at acr.org

  • View Related
  • Share

Most Recently Shared on February 7, 2012 at 5:00 pm By:

RadiologyACR ACR Radiology Medical Society

International Scientific Cooperation to Advance Image-Guided Prostate Cancer Care http://t.co/i2bSPA2R #imaging #prostatecancer

3 months ago...

'Biopsy In A Blood Test' - Effective New Diagnostic For Cancer

medicalnewstoday.com — “Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and anaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 7, 2012 at 8:05 am By:

mnt_pancreatic MNT Pancreatic Can Health News

'Biopsy In A Blood Test' - Effective New Diagnostic For Cancer http://t.co/mlGDHSwi #pancreaticcancer

3 months ago...

Advertisement